Skip to main content
SpringerLink
Log in

Prostate cancer screening: contrasting trends

  • Brief report
  • Published:
Cancer Causes & Control Aims and scope Submit manuscript

Abstract

Purpose

Our previously published data showed rapidly increasing rates of prostate cancer screening in men aged 50–74, which rose from 36 % in 2005 to 48 % in 2008. Based on men’s reported intentions at that time, this was expected to rise to 70 % in 2011. Here we report the actual rate of prostate cancer screening.

Method

Three nationwide observational telephone surveys (EDIFICE opinion polls) were conducted in 2005, 2008, and 2011. The overall target was a representative sample of >1,500 individuals living in France and aged 40–75 years, including 481 men aged 50–74 years.

Results

Within this male population, the rate of screening reported remained stable between 2008 and 2011 (48 and 49 %, respectively). However, comparison of privileged versus disadvantaged populations showed significant differences, with a relative decrease in screening among those of higher socioprofessional status (p = 0.03) and from higher-income groups (p = 0.02). For households with a monthly income above 2,500€, the screening rate decreased from 61 % in 2008 to 51 % in 2011 (p = 0.05), while for those with an income below 2,500€, it increased from 36 % in 2008 to 44 % in 2011 (p = 0.18).

Conclusion

A plateau or even a reduction in prostate cancer screening is currently being observed; this is possibly due to progressive recognition among the population at large of the controversy surrounding prostate cancer screening, whereas this speculation was formerly limited to health-care professionals. After previously being more likely to undergo prostate cancer screening, it is the younger, wealthier populations that are currently showing the most noteworthy step backwards.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Sarfaty M, Wender R, Smith R (2011) Promoting cancer screening within the patient centered medical home. CA Cancer J Clin 61(6):397–408

    Article  PubMed  Google Scholar 

  2. Eisinger F, Morere J, Touboul C, Viguier J, Blay J, Coscas Y, Lhomel C, Pivot X (2014) Vulnerable populations and overconfidence in cancer screening. J Clin Oncol 32 (Suppl):abstr 1574

  3. Wakefield MA, Loken B, Hornik RC (2010) Use of mass media campaigns to change health behaviour. Lancet 376(9748):1262–1271

    Article  Google Scholar 

  4. Salomon L, Peyromaure M, Mongiat-Artus P, Roset F, Gachignard N, Bastide C, Richaud P, Beuzeboc P, Cornud F, Molinie V, Soulie M, Benchikh El Fegoun A (2010) What’s new in 2009 in prostate cancer: highlights from ASTRO, EAU, ASCO and AUA meetings. Prog Urol 20(Suppl 1):S61–S67. doi:10.1016/s1166-7087(10)70030-0

    Article  PubMed  Google Scholar 

  5. HAS (2010) Dépistage du cancer de la prostate. Analyse critique des articles issus des études ERSPC et PLCO publiés en mars 2009. Haute Autorité de Santé, France

  6. Eisinger F, Blay J, Morère J, Rixe O, Calazel-Benque A, Cals L, Coscas Y, Dolbeault S, Namer M, Serin D, Roussel C, Pivot X, Committee E (2008) Cancer screening in France: subjects’ and physicians’ attitudes. Cancer Causes Control 49(4):431–434

    Article  Google Scholar 

  7. Eisinger F, Blay J, Pivot X, Morère J, Coscas Y, Calazel-Benque A, Roussel C, Viguier J (2011) Screening for prostate cancer: growth without control. Eur J Cancer Prev 20(Suppl 1):S33–S35

    Article  PubMed  Google Scholar 

  8. Deville J (1991) A theory of the quota surveys. Surv Methodol 17:173–181

    Google Scholar 

  9. Roussel C, Touboul C (2011) Large population survey: strengths and limits. Methodology of the EDIFICE survey. Eur J Cancer Prev 20(Suppl 1):S5–S7

    Article  PubMed  Google Scholar 

  10. Tuppin P, Samson S, Perrin P, Ruffion A, Millat B, Weill A, Ricordeau P, Allemand H (2012) Prostate-specific antigen use among men without prostate cancer in France (2008–2010). Bull Cancer 99(5):521–527

    PubMed  Google Scholar 

  11. Blay J, Eisinger F, Rixe O, Calazel-Benque A, Morère J, Cals L, Coscas Y, Dolbeault S, Namer S, Serin D, Roussel C, Pivot X (2008) Edifice program: analysis of screening exam practices for cancer in France. Bull Cancer 95(11):1067–1073

    PubMed  Google Scholar 

  12. Barry MJ (2009) Screening for prostate cancer—the controversy that refuses to die. N Engl J Med 360(13):1351–1354

    Article  CAS  PubMed  Google Scholar 

  13. Moyer VA, Force USPST (2012) Screening for prostate cancer: US Preventive Services Task Force recommendation statement. Ann Intern Med 157(2):120–134

    Article  PubMed  Google Scholar 

  14. Lawrentschuk N, Daljeet N, Trottier G, Crawley P, Fleshner NE (2011) An analysis of world media reporting of two recent large randomized prospective trials investigating screening for prostate cancer. BJU Int 108(8 Pt 2):E190–E195

    Article  PubMed  Google Scholar 

  15. Aslani A, Minnillo BJ, Johnson B, Cherullo EE, Ponsky LE, Abouassaly R (2014) The impact of recent screening recommendations on prostate cancer screening in a large health care system. J Urol 191(6):1737–1742. doi:10.1016/j.juro.2013.12.010

    Article  PubMed  Google Scholar 

  16. Cohn JA, Wang CE, Lakeman JC, Silverstein JC, Brendler CB, Novakovic KR, McGuire, Helfand BT (2014) Primary care physician PSA screening practices before and after the final US Preventive Services Task Force recommendation. Urol Oncol. doi:10.1016/j.urolonc.2013.04.013

    Google Scholar 

  17. Weeks BE, Friedenberg LM, Southwell BG, Slater JS (2012) Behavioral consequences of conflict-oriented health news coverage: the 2009 mammography guideline controversy and online information seeking. Health Commun 27(2):158–166

    Article  PubMed  Google Scholar 

  18. McAlearney AS, Oliveri J, Post DM, Song PH, Jacobs E, Waibel J, Harrop JP, Steinmann K, Paskett ED (2012) Trust and distrust among Appalachian women regarding cervical cancer screening: a qualitative study. Patient Educ Couns 86(1):120–126

  19. Eisinger F, Cals L, Calazel-Benque A, Blay J, Coscas Y, Dolbeault S, Namer M, Pivot X, Rixe O, Serin D, Roussel C, Morère J, Committee E (2008) Impact of organised programs on colorectal cancer screening. BMC Cancer 8:104

    Article  PubMed Central  PubMed  Google Scholar 

Download references

Acknowledgments

Roche SA provided funding for the survey, statistical analysis, and organization of working sessions for the study design, data analysis, and manuscript editing.

Conflict of interest

EDIFICE surveys are funded by Roche SA. F Eisinger, JF Morère, X Pivot, Y Coscas, and JY Blay are consultants for Roche SA for these surveys. C Lhomel is an employee of Roche SA.

Author information

Authors and Affiliations

  1. Paoli-Calmettes Institute, UMR_S912, Marseille, France

    F. Eisinger

  2. Oncology Department, Paul Brousse Hospital, Villejuif, France

    J. F. Morère

  3. KantarHealth, Montrouge, France

    C. Touboul

  4. Jean Minjoz University Hospital, Besançon, France

    X. Pivot

  5. Clinique de la Porte de Saint-Cloud, Boulogne-Billancourt, France

    Y. Coscas

  6. Centre Léon Bérard, Lyon, France

    J. Y. Blay

  7. Roche, Boulogne-Billancourt, France

    C. Lhomel

  8. Trousseau Regional University Hospital, Tours, France

    J. Viguier

Authors
  1. F. Eisinger
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. F. Morère
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C. Touboul
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. X. Pivot
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Y. Coscas
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. J. Y. Blay
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. C. Lhomel
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. J. Viguier
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to F. Eisinger.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Eisinger, F., Morère, J.F., Touboul, C. et al. Prostate cancer screening: contrasting trends. Cancer Causes Control 26, 949–952 (2015). https://doi.org/10.1007/s10552-015-0573-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10552-015-0573-9

Keywords

Search

Navigation